Acquisition / mergerNotableFiled on BSE ·

Torrent Pharmaceuticals shareholders approve scheme of amalgamation with JB Pharma

Torrent Pharmaceuticals · Pharmaceuticals & Biotechnology

Arthneeti Research DeskPublished 1 min read

Key highlights

  • NCLT convened meeting held on April 28, 2026 via video conferencing, from 10:00 to 10:21 a.m. IST
  • Scheme of Amalgamation of J. B. Chemicals & Pharmaceuticals Limited into Torrent Pharmaceuticals approved by requisite shareholder majority
  • Voting conducted through remote e-voting and e-voting at the meeting; results and scrutinizer's report to be disclosed to Stock Exchanges separately

Why it's rated notable: Shareholders approved a merger with J. B. Chemicals & Pharmaceuticals Limited, but the filing states no transaction value and the scheme remains subject to further approvals, so the level stays at medium and the event is non-binding.

Original filing

Shareholder Meeting / Postal Ballot-Outcome of Court Convened Meeting

Read the filing on BSE (PDF) →

Companies guiding to strong growth

Ranked by management's own guidance on revenue and margins — not by us.

Rossell Techsys

Aerospace & Defense

Revenue growth 40%+Margin up 2%+

Sign up free to see all 6 →

See full rankings

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

More from Torrent Pharmaceuticals

Other acquisition / merger filings this fortnight

All acquisition / merger filings →

Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.